|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Flecainide
Test Code5309
CPT Codes
80181
Preferred Specimen
2 mL serum collected in a red-top tube (no gel)
Minimum Volume
0.5 mL
Other Acceptable Specimens
Plasma collected in an EDTA (lavender-top) tube
Instructions
Optimum time to collect sample is 1 hour before next dose.
Transport Container
Plastic screw-cap vial
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 5 days
Refrigerated: 7 days
Frozen: 30 days
Refrigerated: 7 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gel barrier/serum separator tube (SST®) • Gross hemolysis • Lipemia
Methodology
Chromatography/Mass Spectrometry
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Tues, Thurs; Report available: 3-7 days
Reference Range
0.20-0.99 mcg/mL
Clinical Significance
Monitoring the Flecainide concentration is used to assure compliance and avoid toxicity of this cardiac drug used to treat ventricular tachycardia and premature contractions.